138 related articles for article (PubMed ID: 36127667)
1. 2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.
Gorphe P; Blanchard P; Garcia GCTE; Classe M; Even C; Temam S; Breuskin I
BMC Cancer; 2022 Sep; 22(1):1000. PubMed ID: 36127667
[TBL] [Abstract][Full Text] [Related]
2. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
3. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa.
Dapaah G; Hille J; Faquin WC; Whittaker J; Dittrich CM; Ebrahim AK; Schneider JW; van Wyk AC; Opperman J; Merven M; Naidoo K; Loock JW; Afrogheh AH
Arch Pathol Lab Med; 2022 Aug; 146(8):1018-1023. PubMed ID: 34871360
[TBL] [Abstract][Full Text] [Related]
5. Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma.
Gorphe P; Classe M; Ammari S; Garcia G; Even C; Casiraghi O; Breuskin I; Tao Y; Temam S; Blanchard P; Moya-Plana A
Radiother Oncol; 2022 Mar; 168():40-45. PubMed ID: 35093406
[TBL] [Abstract][Full Text] [Related]
6. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
[TBL] [Abstract][Full Text] [Related]
7. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
9. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
[TBL] [Abstract][Full Text] [Related]
10. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.
Hong A; Jones D; Chatfield M; Lee CS; Zhang M; Clark J; Elliott M; Harnett G; Milross C; Rose B
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S450-8. PubMed ID: 23208131
[TBL] [Abstract][Full Text] [Related]
11. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
[TBL] [Abstract][Full Text] [Related]
12. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block.
Wilson BL; Israel AK; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993
[TBL] [Abstract][Full Text] [Related]
13. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior.
Alexiev BA; Obeidin F; Johnson DN; Finkelman BS; Prince R; Somani SN; Cheng E; Samant S
Pathol Res Pract; 2020 Dec; 216(12):153243. PubMed ID: 33113454
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
16. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
18. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
Berdugo J; Rooper LM; Chiosea SI
Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
[TBL] [Abstract][Full Text] [Related]
19. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
Lassen P; Primdahl H; Johansen J; Kristensen CA; Andersen E; Andersen LJ; Evensen JF; Eriksen JG; Overgaard J;
Radiother Oncol; 2014 Dec; 113(3):310-6. PubMed ID: 25544647
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]